Track Pfizer Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Pfizer Inc. PFE.VI · Stock Open Pfizer Inc. in new tab

24.10 EUR
P/E
37.08
EPS
0.65
Yield
6.23%
P/B
1.88
ROE
5.01
Beta
0.28
Loading chart...
Key Metrics
P/E37.08
EPS0.65
Book Value12.79
Price to Book1.88
Debt/Equity74.25
% Insiders0.101%
Growth
Revenue Growth0.03%
Dividend
Dividend Yield6.23%
Annual dividends1.51 EUR
Ex-Div. DateJuly 24, 2026
Payout226.32%
5y avg Yield5.19%

DCF Valuation

Tweak assumptions to recompute fair value for Pfizer Inc. (PFE.VI)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Pfizer Inc. Logo Pfizer Inc. Analysis (PFE.VI)

United States Health Care Official Website Stock

Is Pfizer Inc. a good investment? Pfizer Inc. (PFE.VI) is currently trading at 24.10 EUR.

In terms of valuation, the stock trades at a P/E ratio of 37.08. This high multiple suggests investors have priced in significant future growth expectations.

For income investors, Pfizer Inc. pays a dividend yield of 6.23%. With a payout ratio of 226%, the dividend appears to be under pressure.

Investor FAQ

Does Pfizer Inc. pay a dividend?

Yes, it pays an annual dividend of 1.51 EUR (6.23% yield).

What asset class is Pfizer Inc.?

Pfizer Inc. is classified as a Stock. You can compare it against 12 other assets in the "Related Symbols" list on this page.

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Exchange Ticker
MEX (Mexico) PFE.MX
HAN (Germany) PFE.HA
SGO (Chile) PFE.SN
GER (Germany) PFE.DE
HAM (Germany) PFE.HM
BER (Germany) PFE.BE
STO (Sweden) PFE.ST
VIE (Austria) PFE.VI
STU (Germany) PFE.SG
DUS (Germany) PFE.DU
NYQ (United States) PFE
FRA (Germany) PFE.F
Trades
Dividend Yield
6.23%
5y avg 5.19%
Annual Dividends
1.51EUR
Next Ex. Div Date
July 24, 2026
Payout Ratio
226.32%
Dividend History paid per year (EUR)
Historical Dividends
Year Total Dividends
2027
1.14 EUR
July 23, 2027 (estimated) 0.3784
May 28, 2027 (estimated) 0.3784
Jan. 22, 2027 (estimated) 0.3784
2026
1.49 EUR
Nov. 27, 2026 (estimated) 0.3784
July 24, 2026 0.3691
May 8, 2026 0.3691
Jan. 23, 2026 0.3691
2025
1.48 EUR
Nov. 7, 2025 0.3691
July 25, 2025 0.3691
May 9, 2025 0.3691
Jan. 24, 2025 0.3691
2024
1.44 EUR
Nov. 8, 2024 0.3605
July 26, 2024 0.3605
May 9, 2024 0.3605
Jan. 25, 2024 0.3605
2023
1.41 EUR
Nov. 9, 2023 0.3519
July 27, 2023 0.3519
May 11, 2023 0.3519
Jan. 26, 2023 0.3519
2022
1.37 EUR
Nov. 3, 2022 0.3433
July 28, 2022 0.3433
May 12, 2022 0.3433
Jan. 27, 2022 0.3433
2021
1.34 EUR
Nov. 4, 2021 0.3347
July 29, 2021 0.3347
May 6, 2021 0.3347
Jan. 28, 2021 0.3347
2020
1.30 EUR
Nov. 5, 2020 0.3262
July 30, 2020 0.3262
May 7, 2020 0.3262
Jan. 30, 2020 0.3262
2019
1.24 EUR
Nov. 7, 2019 0.3090
Aug. 1, 2019 0.3090
May 9, 2019 0.3090
Jan. 31, 2019 0.3090
2018
1.17 EUR
Nov. 8, 2018 0.2918
Aug. 2, 2018 0.2918
May 11, 2018 0.2918
Feb. 1, 2018 0.2918
2017
0.27 EUR
Aug. 2, 2017 0.2747
Upcoming Dividends
Name Payment Date Status Amount
Pfizer Inc. Jul 24, 2026 0.369069 EUR
Pfizer Inc. May 08, 2026 0.369069 EUR
Pfizer Inc. Jan 23, 2026 0.369069 EUR
Pfizer Inc. Nov 07, 2025 0.369069 EUR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion